Filed: 11/13/2024ACC: 0001104659-24-117555
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 92 equity positions with a total reported market value of $284.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
92
Positions
$284.6K
Total AUM (reported)
16.60M
Total Shares
Allocation by class
COMMON$284.6K100.0%
Portfolio Concentration
Top 3$124.3K43.7%
4–10$69.1K24.3%
11–25$57.0K20.0%
Rest$34.2K12.0%
Top 3 weight
43.7%
Top 10 weight
68.0%
Voting Authority Distribution
Total shares with voting rights: 16.60M
Sole
Full voting authority
16.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other92
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings92
Rows:
Calumet Specialty Products Partners, LP
DFNDShares4.33M
TypeSH
Market value$77.1K
27.08%
Sole
4.33M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$28.1K
9.88%
Sole
225K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$19.1K
6.71%
Sole
112.22K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$16.7K
5.89%
Sole
48K
Shared
0.00
None
0.00
The Panagram BBB-B CLO ETF
DFNDShares542.87K
TypeSH
Market value$14.6K
5.13%
Sole
542.87K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares3.07M
TypeSH
Market value$10.2K
3.58%
Sole
3.07M
Shared
0.00
None
0.00
AbbVie Inc.
DFNDShares5.04K
TypeSH
Market value$9.9K
3.50%
Sole
5.04K
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares224.54K
TypeSH
Market value$6.5K
2.28%
Sole
224.54K
Shared
0.00
None
0.00
Apple Inc.
DFNDShares2.49K
TypeSH
Market value$5.8K
2.04%
Sole
2.49K
Shared
0.00
None
0.00
Medical Facilities Corp
DFNDShares534.21K
TypeSH
Market value$5.3K
1.87%
Sole
534.21K
Shared
0.00
None
0.00
Verona Pharma PLC.
DFNDShares180K
TypeSH
Market value$5.2K
1.82%
Sole
180K
Shared
0.00
None
0.00
OmniAB, Inc.
DFNDShares1.15M
TypeSH
Market value$4.9K
1.71%
Sole
1.15M
Shared
0.00
None
0.00
The Invesco AAA Floating Rate Note ETF
DFNDShares188.89K
TypeSH
Market value$4.8K
1.70%
Sole
188.89K
Shared
0.00
None
0.00
Ardelyx, Inc.
DFNDShares682.87K
TypeSH
Market value$4.7K
1.65%
Sole
682.87K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$4.4K
1.55%
Sole
20.98K
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares332K
TypeSH
Market value$4.4K
1.53%
Sole
332K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares84.83K
TypeSH
Market value$4.3K
1.52%
Sole
84.83K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares212K
TypeSH
Market value$4.2K
1.48%
Sole
212K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares258.23K
TypeSH
Market value$3.6K
1.27%
Sole
258.23K
Shared
0.00
None
0.00
Inozyme Pharma, Inc.
DFNDShares564.55K
TypeSH
Market value$3.0K
1.04%
Sole
564.55K
Shared
0.00
None
0.00
BioCryst Pharmaceuticals Inc.
DFNDShares382K
TypeSH
Market value$2.9K
1.02%
Sole
382K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares1M
TypeSH
Market value$2.9K
1.00%
Sole
1M
Shared
0.00
None
0.00
GSK plc
DFNDShares65K
TypeSH
Market value$2.7K
0.93%
Sole
65K
Shared
0.00
None
0.00
Immunovant Inc.
DFNDShares92K
TypeSH
Market value$2.6K
0.92%
Sole
92K
Shared
0.00
None
0.00
Viking Therapeutics, Inc.
DFNDShares39.04K
TypeSH
Market value$2.5K
0.87%
Sole
39.04K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet Specialty Products Partners, LPDFND | Common | 4.33M | SH | $77.1K 27.08% | 4.33M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $28.1K 9.88% | 225K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $19.1K 6.71% | 112.22K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $16.7K 5.89% | 48K | 0.00 | 0.00 |
The Panagram BBB-B CLO ETFDFND | Common | 542.87K | SH | $14.6K 5.13% | 542.87K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 3.07M | SH | $10.2K 3.58% | 3.07M | 0.00 | 0.00 |
AbbVie Inc.DFND | Common | 5.04K | SH | $9.9K 3.50% | 5.04K | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 224.54K | SH | $6.5K 2.28% | 224.54K | 0.00 | 0.00 |
Apple Inc.DFND | Common | 2.49K | SH | $5.8K 2.04% | 2.49K | 0.00 | 0.00 |
Medical Facilities CorpDFND | Common | 534.21K | SH | $5.3K 1.87% | 534.21K | 0.00 | 0.00 |
Verona Pharma PLC.DFND | Common | 180K | SH | $5.2K 1.82% | 180K | 0.00 | 0.00 |
OmniAB, Inc.DFND | Common | 1.15M | SH | $4.9K 1.71% | 1.15M | 0.00 | 0.00 |
The Invesco AAA Floating Rate Note ETFDFND | Common | 188.89K | SH | $4.8K 1.70% | 188.89K | 0.00 | 0.00 |
Ardelyx, Inc.DFND | Common | 682.87K | SH | $4.7K 1.65% | 682.87K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $4.4K 1.55% | 20.98K | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 332K | SH | $4.4K 1.53% | 332K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 84.83K | SH | $4.3K 1.52% | 84.83K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 212K | SH | $4.2K 1.48% | 212K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 258.23K | SH | $3.6K 1.27% | 258.23K | 0.00 | 0.00 |
Inozyme Pharma, Inc.DFND | Common | 564.55K | SH | $3.0K 1.04% | 564.55K | 0.00 | 0.00 |
BioCryst Pharmaceuticals Inc.DFND | Common | 382K | SH | $2.9K 1.02% | 382K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 1M | SH | $2.9K 1.00% | 1M | 0.00 | 0.00 |
GSK plcDFND | Common | 65K | SH | $2.7K 0.93% | 65K | 0.00 | 0.00 |
Immunovant Inc.DFND | Common | 92K | SH | $2.6K 0.92% | 92K | 0.00 | 0.00 |
Viking Therapeutics, Inc.DFND | Common | 39.04K | SH | $2.5K 0.87% | 39.04K | 0.00 | 0.00 |
Page 1 of 4